Redox pathways in the mitochondrion
6,9 However, Arjinpathana and Asawanonda 1 reported many contradictory results regarding the efficacy and safety of glutathione as a skin-lightening agent
Volanesorsen was approved by the EMA for use in patients with familial chylomicronemia syndrome, but was not approved by the FDA because of the risk of thrombocytopenia
They suppress appetite through hypothalamic signaling, enhance insulin sensitivity, reduce glucagon secretion, and slow gastric emptying
The pill was approved for chronic weight management in adults with obesity or overweight and at least one related health condition, broadening the potential patient pool at a time when insurers, employers and governments are wrestling with spiraling healthcare costs related to obesity
Clinicians should record baseline heart rate before initiating treatment and reassess at each follow-up appointment